Home Cart 0 Sign in  

[ CAS No. 76-83-5 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 76-83-5
Chemical Structure| 76-83-5
Structure of 76-83-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 76-83-5 ]

Related Doc. of [ 76-83-5 ]

Alternatived Products of [ 76-83-5 ]

Product Details of [ 76-83-5 ]

CAS No. :76-83-5 MDL No. :MFCD00000813
Formula : C19H15Cl Boiling Point : -
Linear Structure Formula :- InChI Key :JBWKIWSBJXDJDT-UHFFFAOYSA-N
M.W :278.78 Pubchem ID :6456
Synonyms :

Calculated chemistry of [ 76-83-5 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.05
Num. rotatable bonds : 3
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 85.06
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.27 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.21
Log Po/w (XLOGP3) : 5.25
Log Po/w (WLOGP) : 5.11
Log Po/w (MLOGP) : 5.62
Log Po/w (SILICOS-IT) : 5.53
Consensus Log Po/w : 4.94

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.34
Solubility : 0.00126 mg/ml ; 0.00000453 mol/l
Class : Moderately soluble
Log S (Ali) : -5.0
Solubility : 0.00279 mg/ml ; 0.00001 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -8.09
Solubility : 0.00000225 mg/ml ; 0.0000000081 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.27

Safety of [ 76-83-5 ]

Signal Word:Danger Class:8
Precautionary Statements:P280-P305+P351+P338-P310-P405-P501 UN#:3261
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 76-83-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 76-83-5 ]
  • Downstream synthetic route of [ 76-83-5 ]

[ 76-83-5 ] Synthesis Path-Upstream   1~61

  • 1
  • [ 76-83-5 ]
  • [ 50-89-5 ]
  • [ 7791-71-1 ]
YieldReaction ConditionsOperation in experiment
97.1% at 20℃; for 21.5 h; Synthesized in the following manner according to literature [Nucleosides Nucleotides, 8, 1529-1535 (1989)]: In a stream of nitrogen, triphenylmethyl chloride (15 g, 53.7 mmols) was added to a pyridine (40 ml) solution of thymidine (10 g, 41.3 mmols) at room temperature, and the mixture was stirred for 21.5 hours at room temperature. A saturated aqueous solution of sodium bicarbonate was added to the reaction mixture, and the system was extracted with a methylene chloride solution. The organic layer was washed with a saturated aqueous solution of sodium chloride, and then dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (ethyl acetate:n-hexane = 1:1)* to obtain Compound 41 (19.4 g, 97.1percent) as a colorless acicular substance.
48% at 65℃; for 16 h; Inert atmosphere In a 25ml round bottom flask 100mg (0.39mmol) of4was evaporated 3 times with 3mL of dry pyridine and dissolved in 3mL of dry pyridine. Trityl chloride (120.0mg, 0.43mmol) was added and the reaction mixture was heated at 65°C for 16h under argon atmosphere. After 16h, the mixture was cooled to room temperature, quenched with 3mL of MeOH and stirred for 30min. The mixture was evaporated to dryness. The obtained crude compound was purified by column chromatography to obtain 92mg (48percent) of17. TLC (CH2Cl2/MeOH, 9:1):Rf=0.70.1H NMR (500MHz, CDCl3):δ8.61 (bs, 1H), 7.56 (s, 1H), 7.42–7.26 (m, 15H), 6.42–6.40 (m, 1H, H-1′), 4.58 (s, 1H), 4.20–4.10 (m, 1H), 3.49–3.46 (m, 1H), 3.40–3.37 (m, 1H), 2.44–2.40 (m, 1H, H-2′/H-2″), 2.34–2.30 (m, 1H, H-2′/H-2″), 1.48 (s, 3H, 5-CH3).13C NMR (125MHz, CDCl3):δ163.6, 150.3, 143.3, 135.5, 128.6, 128.2, 128.0, 127.5, 111.3, 87.5, 86.0, 84.6, 72.4, 70.7, 63.7, 40.9, 11.9; HRMS (EI+): m/z for [C42H48N4O10Na]+, calcd. 507.1890; found 507.1907.
Reference: [1] Patent: EP1486504, 2004, A1, . Location in patent: Page 27; 28; 29
[2] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 6, p. 2819 - 2828
[3] Journal of Nanoscience and Nanotechnology, 2013, vol. 13, # 7, p. 4593 - 4600
[4] Journal of Pharmaceutical Sciences, 1985, vol. 74, # 3, p. 246 - 249
[5] Organic and Biomolecular Chemistry, 2010, vol. 8, # 2, p. 391 - 397
[6] Tetrahedron Letters, 2003, vol. 44, # 2, p. 293 - 297
[7] Tetrahedron Letters, 1999, vol. 40, # 9, p. 1787 - 1790
[8] Tetrahedron Letters, 1992, vol. 33, # 19, p. 2645 - 2648
[9] European Journal of Medicinal Chemistry, 2014, vol. 76, p. 98 - 109
[10] Journal of Fluorine Chemistry, 1991, vol. 55, # 3, p. 283 - 289
[11] Nucleosides and Nucleotides, 1995, vol. 14, # 1-2, p. 209 - 218
[12] Journal of Medicinal Chemistry, 1995, vol. 38, # 14, p. 2672 - 2680
[13] Synthetic Communications, 2000, vol. 30, # 21, p. 3873 - 3882
[14] Tetrahedron Letters, 2003, vol. 44, # 47, p. 8571 - 8575
[15] Journal of the Chemical Society, 1953, p. 951,954
[16] Journal of Biological Chemistry, 1935, vol. 109, p. 623,626
[17] Journal of the American Chemical Society, 1958, vol. 80, p. 6212,6220
[18] Journal of Organic Chemistry, 2006, vol. 71, # 15, p. 5774 - 5777
[19] Patent: US4788181, 1988, A,
[20] Patent: US2004/110720, 2004, A1,
[21] Patent: US7544794, 2009, B1, . Location in patent: Page/Page column 12
[22] Journal of Medicinal Chemistry, 2010, vol. 53, # 10, p. 4130 - 4140
[23] Journal of Medicinal Chemistry, 2010, vol. 53, # 19, p. 7156 - 7166
[24] Chinese Chemical Letters, 2011, vol. 22, # 8, p. 899 - 902
[25] Heterocyclic Communications, 2015, vol. 21, # 5, p. 291 - 295
  • 2
  • [ 76-83-5 ]
  • [ 50-89-5 ]
  • [ 7791-71-1 ]
  • [ 52417-07-9 ]
Reference: [1] ChemistryOpen, 2016, vol. 5, # 3, p. 227 - 235
[2] European Journal of Medicinal Chemistry, 2013, vol. 65, p. 249 - 255
  • 3
  • [ 76-83-5 ]
  • [ 16053-52-4 ]
  • [ 7791-71-1 ]
Reference: [1] Journal of Organic Chemistry, 2016, vol. 81, # 22, p. 10742 - 10758
  • 4
  • [ 76-83-5 ]
  • [ 50-89-5 ]
  • [ 73189-04-5 ]
  • [ 7791-71-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1992, vol. 29, # 6, p. 1405 - 1407
  • 5
  • [ 288-32-4 ]
  • [ 76-83-5 ]
  • [ 15469-97-3 ]
YieldReaction ConditionsOperation in experiment
95.6%
Stage #1: With triethylamine In N,N-dimethyl-formamide at 0℃; for 0.5 h; Large scale
Stage #2: at 0 - 15℃; for 16 h; Large scale
Compound XIII (880g, 12.9mol, 1.0eq.) In the autoclave 50L, 12L DMF were dissolved, cooled To below 0 °C, triethylamine (1308g, 12.9mol, 1.0eq. ) The reaction was kept 30min, 0 ° C solution of the following threePhenyl chloride (3605.0g, 12.9mol, 1.0eq. ) In DMF (16L), drops Bi, 15 ° C overnight with stirring 16 h. Thereaction mixture was poured into water, large amount of solid precipitated, suction filtered, the filter cake washedwith water, drained, dried to obtain compound XIV-1 White The solid 3835.1g, Yield: 95.6percent.
91%
Stage #1: With triethylamine In N,N-dimethyl-formamide at 0℃; for 0.5 h;
Stage #2: at 0 - 20℃;
1-trityl-midazol (Compound 28, Scheme 19) was prepared by adding Et3N (5.1 ml, 36.7 mmol) at 0° C. to a stirred solution of the imidazole Compound 27 (2.5 grams, 36.7 mmol) dissolved in 75 ml DMF. After 30 minutes of stirring, trityl-chloride (10.3 grams, 36.7 mmol) dissolved in DMF (45 ml) was added slowly to the reaction mixture, and the reaction mixture was allowed to reach room temperature while stirred continuously for over night. Thereafter the reaction mixture was quenched with cold water (1 L) to precipitate a solid, which was collected by filtration and recrystallized from hexane/DCM to afford Compound 28 as a white solid (91percent yield).1H NMR (500 MHz, CDCl3)-δ: 7.47 (s, 1H), 7.33-7.30 (m, 9H), 7.16-7.12 (m, 6H), 7.07 (s, 1H), 6.83 (s, 1H).
90% With ammonium chloride; triethylamine In dichloromethane Example 22
Synthesis of 1-tritylimidazole (5)
To a solution of trityl chloride (5.58 g, 20.0 mmol.) in dry methylene chloride (100 ml) cooled down to 0° C. and stirred under Ar, was added dropwise over 1.5 hours a solution of imidazole (1.36 g, 20.0 mmol.) and triethylamine (2.7 mml, 20 mmol.) in 50 ml dry methylene chloride.
At the end of the addition, the reaction mixture was allowed to warm up to room temperature and stirred under Ar at that temperature overnight.
The reaction mixture was then washed with 20 ml of a 10percent solution of ammonium chloride, then with 20 ml of distilled water.
The organic phase was dried over magnesium sulfate and evaporated in vacuo to yield quantitatively a white solid.
Recrystallization from methylene chloride/hexanes yielded 5.60 g of (5) (yield=90percent after recrystallization).
m.p. 214° C.; 1H NMR (200 MHz, CDCl3) δ7.43 (m, 1H, NCHN), 7.3-7.4 (m, 9H, 3*C6H5), 7.1-7.2 (m, GH, 3*C6H5), 7.0 (m, 1H, Ph3CNCH=CH), 6.81 (m, 1H, Ph3CNCH=CH); 13C NMR (50 MHz, CDCl3) δ142.3, 139.0, 129.6, 128.2, 128.3, 121.6.
90% With ammonium chloride; triethylamine In dichloromethane Example 22
Synthesis of 1-tritylimidazole (5) STR73
To a solution of trityl chloride (5.58 g, 20.0 mmol.) in dry methylene chloride (100 ml) cooled down to 0° C. and stirred under Ar, was added dropwise over 1.5 hours a solution of imidazole (1.36 g, 20.0 mmol.) and triethylamine (2.7 mml, 20 mmol.) in 50 ml dry methylene chloride.
At the end of the addition, the reaction mixture was allowed to warm up to room temperature and stirred under Ar at that temperature overnight.
The reaction mixture was then washed with 20 ml of a 10percent solution of ammonium chloride, then with 20 ml of distilled water.
The organic phase was dried over magnesium sulfate and evaporated in vacuo to yield quantitatively a white solid.
Recrystallization from methylene chloride/hexanes yielded 5.60 g of (5) (yield=90percent after recrystallization).
m.p. 214° C.; 1 H NMR (200 MHz, CDCl3) δ 7.43 (m, 1H, NCHN), 7.3-7.4 (m, 9H, 3xC6 H5), 7.1-7.2 (m, 6H, 3xC6 H5), 7.0 (m, 1H, Ph3 CNCH=CH), 6.81 (m, 1H, Ph3 CNCH=CH); 13 C NMR (50 MHz, CDCl3) δ 142.3, 139.0, 129.6, 128.2, 128.3, 121.6.
90% With ammonium chloride; triethylamine In dichloromethane Example 22
Synthesis of 1-tritylimidazole (5) STR70
To a solution of trityl chloride (5.58 g, 20.0 mmol.) in dry methylene chloride (100 ml) cooled down to 0° C. and stirred under Ar, was added dropwise over 1.5 hours a solution of imidazole (1.36 g, 20.0 mmol.) and triethylamine (2.7 mml, 20 mmol) in 50 ml dry methylene chloride.
At the end of the addition, the reaction mixture was allowed to warm up to room temperature and stirred under Ar at that temperature overnight.
The reaction mixture was then washed with 20 ml of a 10percent solution of ammonium chloride, then with 20 ml of distilled water.
The organic phase was dried over magnesium sulfate and evaporated in vacuo to yield quantitatively a white solid.
Recrystallization from methylene chloride/hexanes yielded 5.60 g of (5) (yield=90percent after recrystallization).
m.p. 214° C.; 1 H NMR (200 MHz, CDCl3) δ7.43 (m, 1H, NCHN), 7.3-7.4 (m, 9H, 3*C6 H5), 7.1-7.2 (m, 6H, 3*C6 H5), 7.0 (m, 1H, Ph3 CNCH=CH), 6.81 (m, 1H, Ph3 CNCH=CH); 13 C NMR (50 MHz, CDCl3) δ142.3, 139.0, 129.6, 128.2, 128.3, 121.6.

Reference: [1] Patent: CN104086553, 2016, B, . Location in patent: Paragraph 0065-0068
[2] Patent: US2010/16610, 2010, A1, . Location in patent: Page/Page column 28
[3] Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 253 - 256
[4] Tetrahedron, 1999, vol. 55, # 13, p. 4109 - 4122
[5] Patent: US6476216, 2002, B1,
[6] Patent: US6160109, 2000, A,
[7] Patent: US5734041, 1998, A,
[8] Journal of Heterocyclic Chemistry, 1995, vol. 32, # 3, p. 903 - 906
[9] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 1, p. 2 - 6
[10] European Journal of Organic Chemistry, 2011, # 30, p. 6092 - 6099
[11] Heterocycles, 1985, vol. 23, # 11, p. 2895 - 2906
[12] Arzneimittel-Forschung/Drug Research, 1992, vol. 42, # 6, p. 832 - 835
[13] Journal of Heterocyclic Chemistry, 1994, vol. 31, # 4, p. 857 - 860
[14] Patent: US5039691, 1991, A,
[15] ChemMedChem, 2010, vol. 5, # 6, p. 899 - 910
  • 6
  • [ 28697-53-2 ]
  • [ 3473-63-0 ]
  • [ 76-83-5 ]
  • [ 15469-97-3 ]
  • [ 142822-28-4 ]
  • [ 33769-07-2 ]
Reference: [1] Tetrahedron, 1992, vol. 48, # 21, p. 4327 - 4346
  • 7
  • [ 2075-45-8 ]
  • [ 76-83-5 ]
  • [ 95162-14-4 ]
YieldReaction ConditionsOperation in experiment
98.2% With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; Inert atmosphere A 500 mL Schlenk flask backfilled with N2was added 4-bromo-1H-pyrazole (10.0g, 68.0 mmol) and dry THF (250 mL). The resulting solution was cooled to 0 °C understirring before 60percent NaH dispersion (3.3 g, 81.6 mmol) was added slowly. Once H2evolution had ceased, trityl chloride (20.9 g, 74.8 mmol) was added slowly, andthe resulting mixture was stirred overnight at RT before quenching with H2O(5 mL) and drying in vacuo.Theresulting residue was triturated in dichloromethane (5 mL) and methanol (200mL) for 2 hours.The resulting suspension wasfiltered and dried overnight at 50°C to give4-bromo-1-trityl-1H-pyrazole(26.0g, 66.8 mmol, 98.2percent) as a white solid.1HNMR (300 MHz, DMSO-d6)δ = 7.03 – 7.06 (m, 6 H), 7.34 – 7.40 (m, 9 H), 7.51 (s, 1 H), δ 7.76 (s, 1H).
96% With pyridine In dichloromethane at 20℃; for 16 h; A solution of 150 g (1.0 mol) of 4-bromo-1H-pyrazole, 334 g (1.2 mol, 1.2 eq.) of trityl chloride, 158 g (2.0 mol, 2.0 eq.) of pyridine and 6.1 g (0.05 mol, 5 mol percent) of 4-dimethylaminopyridine in 2 L of dichloromethane was stirred at room temperature for 16 h.
The resulting mixture was washed with water and saturated aqueous ammonium chloride solution.
The organic layer was dried over sodium sulfate and concentrated.
The residue was triturated with hexanes to give 380 g (96percent) of 4-bromo-1-trityl-1H-pyrazole.
87% With triethylamine In N,N-dimethyl-formamide at 70℃; for 3 h; Manufacturing Example 32-1-1 4-Bromo-1-trityl-1H-pyrazole; To a solution of 4-bromopyrazole (10.0 g, 68.0 mmol) in N,N-dimethylformamide (100 mL) was added dropwise triethylamine (23.7 mL, 170 mmol) under nitrogen atmosphere at room temperature. Trityl chloride (37.9 g, 136 mmol) was added to the reaction solution on an ice bath (0° C.), and stirred for 3 hours at 70° C. Water (400 mL) was added to the reaction solution to precipitate the solids. The precipitated solids were filtered and dried under a reduced pressure. The solids were then azeotropically dried with toluene to obtain the title compound (22.9 g, 87percent).1H-NMR Spectrum (DMSO-d6) δ (ppm): 7.04-7.07 (6H, m), 7.35-7.38 (9H, m), 7.52 (1H, d, J=0.4 Hz), 7.76 (1H, d, J=0.8 Hz).
87% With triethylamine In N,N-dimethyl-formamide at 0 - 70℃; for 3 h; To a solution of 4-bromopyrazole (10.0 g, 68.0 mmol) in N,N-dimethylformamide (100 mL) was added dropwise triethylamine (23.7 mL, 170 mmol) under nitrogen atmosphere at room temperature. Trityl chloride (37.9 g, 136 mmol) was added to the reaction solution on an ice bath (0° C.), and stirred for 3 hours at 70° C. Water (400 mL) was added to the reaction solution to precipitate the solids. The precipitated solids were filtered and dried under a reduced pressure. The solids were then azeotropically dried with toluene to obtain the title compound (22.9 g, 87percent). 1H-NMR Spectrum (DMSO-d6) δ (ppm): 7.04-7.07 (6H, m), 7.35-7.38 (9H, m), 7.52 (1H, d, J=0.4 Hz), 7.76 (1H, d, J=0.8 Hz).

Reference: [1] Tetrahedron Letters, 2016, vol. 57, # 8, p. 895 - 898
[2] Patent: US2008/261975, 2008, A1, . Location in patent: Page/Page column 12
[3] Journal of the American Chemical Society, 2011, vol. 133, # 31, p. 12285 - 12292
[4] Patent: US2009/82403, 2009, A1, . Location in patent: Page/Page column 81
[5] Patent: US2007/105904, 2007, A1, . Location in patent: Page/Page column 78
[6] Heterocycles, 2010, vol. 81, # 6, p. 1509 - 1516
[7] Journal of Medicinal Chemistry, 1998, vol. 41, # 13, p. 2390 - 2410
[8] Synthesis, 1997, # 5, p. 563 - 566
[9] Organic Letters, 2015, vol. 17, # 5, p. 1142 - 1145
[10] Journal of Organic Chemistry, 2018, vol. 83, # 5, p. 2954 - 2958
[11] Patent: US6492416, 2002, B1,
[12] Patent: US6200978, 2001, B1,
[13] Patent: WO2007/52943, 2007, A1, . Location in patent: Page/Page column 20-21
[14] Patent: US2008/287440, 2008, A1, . Location in patent: Page/Page column 5
[15] Patent: WO2003/104200, 2003, A1, . Location in patent: Page 20
[16] Patent: WO2003/104189, 2003, A2, . Location in patent: Page 16
  • 8
  • [ 288-88-0 ]
  • [ 76-83-5 ]
  • [ 31250-99-4 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With triethylamine In N,N-dimethyl-formamide for 0.0833333 h;
j0185j Triethylamine (5.49 g, 54.30 mmol) is added to a solution of 1,2,4-triazole (3.0 g, 43.44 mmol) in DMF (50 mL) at rt. After stirring for 5 minutes, trityl chloride (12.11 g, 43.44 mmol) is added as a solid and the mixture is stirred overnight. The solvent is distilled off under reduced pressure and the crude is partitioned between dichloromethane (50 mL) and water (50 mL). The organic layer is separated and the aqueous layer is extracted with dichloromethane (3 x 50 mL). The combined organic layers are washed with water (3 x 40 mL). The organic layer is dried over Na2SO4 and concentrated under reduced pressure to afford the product 1-trytil-1H- 1,2,4-triazole (12.6 g, 93 percent). n-BuLi (4.5 mL, 11.24 mmol; 2.5 M solution in hexanes) is added to a solution of 1-trityl-1H-1,2,4-triazole (3.5 g, 11.24 mmol) in THF (120 mL) at -78°C and the solution is stirred for 45 mm. Bromine (1.76 g, 11.02 mmol) is added dropwise over a period of 5 minutes and the solution is stirred for 2 h allowed to warm to -20 °C and quenched by adding saturated NH4C1 solution (30 mL). The reaction mixture ias diluted with water (60 mL) and dichloromethane (40 mL). The organic layer is separated and the aqueous layer is extracted with CH2C12 (4 x 50 mL).The combined organic extract was dried over Na2SO4 and the solvent evaporated under reduced pressure to afford crude which is used as such for the next step (4.2 g, 95 percent). 7.09-7.16 (m, 6H), 7.27-7.40 (m, 9H), 7.86 (s, 1H).
Reference: [1] Patent: WO2014/159248, 2014, A1, . Location in patent: Paragraph 0185
[2] European Journal of Medicinal Chemistry, 2009, vol. 44, # 7, p. 3064 - 3067
[3] Tetrahedron, 1997, vol. 53, # 30, p. 10289 - 10312
[4] MedChemComm, 2014, vol. 5, # 1, p. 72 - 81
[5] Patent: US6620841, 2003, B1,
[6] Patent: EP1219607, 2002, A1,
[7] Heterocycles, 1985, vol. 23, # 11, p. 2895 - 2906
[8] Patent: US5393732, 1995, A,
  • 9
  • [ 288-88-0 ]
  • [ 76-83-5 ]
  • [ 136633-98-2 ]
  • [ 31250-99-4 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1991, vol. 110, # 9, p. 369 - 373
[2] Tetrahedron Letters, 2000, vol. 41, # 8, p. 1297 - 1301
  • 10
  • [ 76-83-5 ]
  • [ 23785-21-9 ]
  • [ 53525-60-3 ]
YieldReaction ConditionsOperation in experiment
55% With triethylamine In N,N-dimethyl-formamide at 0 - 20℃; for 12 h; To a stirred solution of XLIV, (2 g; 14 mmol) in dimethylformide (50 ml) was added trityl chloride (3.98 g; 14 mmol) and triethylamine (1.73 g, 17 mmol) at 0°C. The resulting solution was stirred for 12 h at room temperature. The reaction mixture was cooled, concentrated at reduced pressure and diluted with water. The aqueous layer was extracted with ethyl acetate.The combined organic layers were washed with brine, dried over Na2504, filtered and concentrated under vacuum to afford ethyl 1 -trityl- 1 H-imidazole-4-carboxylate as a brown solid (XLV; 3 g, 55percent yield). MS (M+1) 383.34.
Reference: [1] Farmaco, Edizione Scientifica, 1985, vol. 40, # 8, p. 541 - 554
[2] Patent: WO2015/97122, 2015, A1, . Location in patent: Page/Page column 96; 97
[3] Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 253 - 256
[4] Patent: US4935437, 1990, A,
[5] Patent: US2016/272594, 2016, A1, . Location in patent: Paragraph 0023
  • 11
  • [ 76-83-5 ]
  • [ 79848-49-0 ]
  • [ 32926-43-5 ]
Reference: [1] Chemistry of Natural Compounds, 1982, vol. 18, # 3, p. 322 - 327[2] Khimiya Prirodnykh Soedinenii, 1982, # 3, p. 349 - 354
  • 12
  • [ 5400-78-2 ]
  • [ 76-83-5 ]
  • [ 519-73-3 ]
  • [ 121-89-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2013, vol. 11, # 12, p. 1978 - 1999
  • 13
  • [ 76-83-5 ]
  • [ 3034-50-2 ]
  • [ 33016-47-6 ]
YieldReaction ConditionsOperation in experiment
100% With triethylamine In N,N-dimethyl-formamide at 0 - 20℃; Example 33: 1 -trityl-1 H-imidazole-4-carbaldehydeTo a solution of 1W-imidazole-4-carbaldehyde {30.0 g, 0.30 mol) in DMF (200 mL) was added Et3N (70 mL, 0.375 mol) under ice bath, and then Trt-CI (105 g, 0.375 mol) was added in portions and the mixture stirred at RT overnight. The mixture was evaporated in vacuo and the residue was washed with anhydrous Et2O (4 x 50 mL), and the resulting precipitate was dried to yield the title compound (100 g, 100percent) as a yellow solid.
98% With triethylamine In dichloromethane at 0 - 20℃; [2372] To a stirred solution of 4(5)-imidazolecarboxaldehyde (20.0 g, 0.208 mmol) in CH2Cl2 (200 mL), was added Et3N (29.0 mL, 0.208 mmol). The solution was then cooled down at 0° C., followed by addition of triphenylmethylchloride (52.8 g, 0.18 mmol) at 0° C. The resulting solution was stirred at room temperature overnight and then washed it with brine, water and concentrated to dryness to give a white solid (63.0 g, 98percent yield, MH+=339.1)
96% With triethylamine In acetonitrile Dry triethylamine (12.6 mL, 90.0 mmol) was added drop wise over two hours to a slurry of (l,3)-H-imidazole-4-carbaldehyde (5.0 g, 52 mmol) and trityl chloride (16.0 g, 57.0 mmol) in acetonitrile (170 mL). After complete addition of the triethylamine, the resulting solution was stirred overnight and then hexane (16.6 mL) and water (170 mL) were added. After stirring for an additional 30 minutes, the resulting solid was collected and dried overnight under vacuum to provide the title compound as a white solid (16.8 g, 96percent). 1H NMR (400 MHz, CDCl3): δ 9.81 (s, IH), EPO <DP n="24"/>7.54 (s, IH), 7.46 (s, IH), 7.29 (m, 10H), 7.04 (m, 5H). 13C NMR (100 MHz, CDCl3): δ 186.9, 141.9, 141.2, 141.0, 130.0, 129.0, 128.9, 127.2, 76.7.
95% With alkaline condition In acetonitrile at 20℃; for 2 h; To a mixture of 10 (1.03 g, 10.7 mmol) and TrCl (3.29 g, 11.8 mmol, 1.1 eq) in MeCN (45 mL) was added Et3N (2.5 mL, 18.0 mmol, 1.7 eq) at rt. After stirring for 2 h, hexane (3 mL) and H2O (40 mL) were added and the mixture was filtered. The resultant cake was washed with water three times and dried in a house vacuumoven at 50 °C to afford 18 (3.42 g, 95percent) as a white powder.1H NMR (500 MHz, CDCl3) δ 7.10-7.13 (m, 5H), 7.35-7.38 (m, 10H), 7.53 (d, J = 1.1 Hz, 1H), 7.61 (d, J =1.7 Hz, 1H), 9.88 (s, 1H)
78% With triethylamine; citric acid In <i>N</i>-methyl-acetamide; ethyl acetate Synthesis of 1-Trityl-1H-imidazole-4-carbaldehyde STR49
To dimethylformamide (100 mL) was added imidazole-4-carboxaldehyde (10 g, 0.104 mol, Aldrich Chemical Corp.) and triethylamine (20.5 mL, 0.147 mol).
A solution of trityl chloride (40 g, 0.143 mol) in dimethylformamide (300 mL) was added, followed by stirring at 25° C. for 6 hours.
The solvent was removed in vacuo, and the residue was dissolved in ethyl acetate (1.5 L) and 1N citric acid (350 mL).
The phases were separated, and the organic phase was washed with brine, dried over anhydrous magnesium sulfate, and filtered.
Concentration of the solution in vacuo gave a white solid, 27.59 g, 78percent yield. NMR was consistent with structure. MS: APCI: M-1: 337.2 (M: 338.41).
67% With triethylamine In N,N-dimethyl-formamide at 20℃; for 18 h; Intermediate 18:l-trityl-lH-imidazole-4-carbaldehyde[00417 ] Triethylamine (3.05 ml, 21.86 mmol) was added to a solution of lH-imidazole-4- carbaldehyde (2 g, 20.82 mmol) and triphenylmethyl chloride (5.80 g, 20.82 mmol) in N5N- dimethylformamide (20 ml). The reaction mixture was stirred at room temperature for 18 hours. The crude mixture was concentrated in vacuo and partitioned between ethyl acetate and water. The organic phase was washed dried over sodium sulfate, filtered and concentrated in vacuo. The residue was recrystallised from dichloromethane and hexanes to afford the title compound as a cream solid (4.7 g, 67percent yield).[00418] 1H NMR (DMSO-d6, 400 MHz) δ 7.10-7.16 (6H, m), 7.36-7.57 (9H, m), 7.63 (IH, s), 7.64 (IH, s), 9.91 (IH, s).
65% With triethylamine In ISOPROPYLAMIDE at 25℃; for 24 h; Reference Example 11 To 4 (5) -formylimidazole (2 g, 20.8 mmol) were added D Ac (30 mL) and triethylamine (3.5 mL, 25.0 mmol, 1.2 equivalents), and then trityl chloride (4.06 g, 14.6 mmol, 0.7 equivalents) was added thereto at room temperature. The mixture was stirred at room temperature for 24 hr, and to the reaction mixture was added water (60 mL) at room temperature, and the mixture was stirred at room temperature for 2 hr. The crystals werecollected by filtration, washed with water, and vacuum-dried(50°C) to a constant amount to give a crude compound (4.6 g) . To the crude compound (0.2 g) was added methanol (1 mL) , and the. mixture was stirred at room temperature for 2 hr. The crystals were collected by filtration, was washed withmethanol (0.2 mL) , and vacuum-dried (50°C) to a constant amount to give l-trityl-4-formyl-lH-imidazole (0.14 g) . yield 65percent.
10 g With triethylamine In N,N-dimethyl-formamide at 0 - 35℃; A)
1-trityl-1H-imidazol-4-carbaldehyde
A mixture of 1H-imidazol-4-carbaldehyde (3.00 g), triethylamine (7.00 g) and N,N-dimethylformamide (40 mL) was cooled to 0°C, trityl chloride (10.5 g) was added thereto.
The reaction mixture was stirred at room temperature for 18 hr, water was added thereto, and the solid was collected by filtration.
The obtained solid was washed with water and diethyl ether to give the title compound (10.0 g).
1H NMR (400 MHz, DMSO-d6) δ 7.11-7.14 (6H, m), 7.40-7.48 (9H, m), 7.67 (1H, d, J = 0.8 Hz), 7.80 (1H, d, J = 1.2 Hz), 9.23 (1H, s).

Reference: [1] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 23, p. 7993 - 8002
[2] Patent: WO2008/4096, 2008, A1, . Location in patent: Page/Page column 79
[3] Journal of Medicinal Chemistry, 2002, vol. 45, # 1, p. 177 - 188
[4] European Journal of Organic Chemistry, 2015, vol. 2015, # 18, p. 3957 - 3962
[5] Patent: US2004/122018, 2004, A1, . Location in patent: Page 317
[6] Organic and Biomolecular Chemistry, 2011, vol. 9, # 7, p. 2274 - 2278
[7] Journal of Medicinal Chemistry, 2011, vol. 54, # 6, p. 1693 - 1703
[8] Angewandte Chemie - International Edition, 2005, vol. 44, # 31, p. 4903 - 4906
[9] Journal of Medicinal Chemistry, 2006, vol. 49, # 19, p. 5710 - 5727
[10] Patent: WO2006/102159, 2006, A2, . Location in patent: Page/Page column 21; 22
[11] Chemistry - A European Journal, 2006, vol. 12, # 16, p. 4321 - 4332
[12] Synlett, 2016, vol. 27, # 19, p. 2734 - 2736
[13] Chemical Communications, 2011, vol. 47, # 48, p. 12855 - 12857
[14] Patent: US6143766, 2000, A,
[15] Journal of Medicinal Chemistry, 2010, vol. 53, # 4, p. 1712 - 1725
[16] Patent: WO2008/94992, 2008, A2, . Location in patent: Page/Page column 188
[17] Tetrahedron Letters, 2006, vol. 47, # 8, p. 1253 - 1255
[18] Patent: WO2012/173280, 2012, A1, . Location in patent: Page/Page column 35-36
[19] Patent: US2003/199522, 2003, A1,
[20] Patent: US2002/82272, 2002, A1,
[21] Patent: WO2010/52256, 2010, A1, . Location in patent: Page/Page column 37
[22] Patent: WO2010/52255, 2010, A1, . Location in patent: Page/Page column 68
[23] Patent: WO2006/23720, 2006, A2, . Location in patent: Page/Page column 48
[24] Patent: US2007/49616, 2007, A1, . Location in patent: Page/Page column 29
[25] Patent: EP2848618, 2015, A1, . Location in patent: Paragraph 0816
[26] ChemMedChem, 2018, vol. 13, # 8, p. 842 - 851
  • 14
  • [ 3034-50-2 ]
  • [ 76-83-5 ]
  • [ 33016-47-6 ]
YieldReaction ConditionsOperation in experiment
98% at 0 - 20℃; [1815] To a stirred solution of 4(5)-imidazolecarboxaldehyde (20.0 g, 0.208 mmol) in CH2Cl2 (200 mL), was added Et3N (29.0 mL, 0.208 mmol). The solution was then cooled down at 0° C., followed by addition of triphenylmethylchloride (52.8 g, 0.18 mmol) at 0° C. The resulting solution was stirred at room temperature overnight and then washed it with brine, water and concentrated to dryness to give a white solid (63.0 g, 98percent yield, MH+=339.1)
94% With triethylamine In acetonitrile at 20℃; for 20.3333 h; To a 1L three-necked round-bottomed flask with an addition funnel was added 3H-imidazole-4-carbaldehyde (4, 12 g, 0.125 mol) trityl chloride (38.3 g, 0.137 mol) and acetonitrile (400 mL). The mixture was stirred at rt to give a slurry. Triethylamine (30 mL, 0.215 mol) was added drop wise over 20 min. After the addition was complete, the reaction mixture was stirred at rt for 20 h. Hexane (40 mL) and water (400mL) were added. The slurry was stirred for 30 min and filtered. The cake was washed with water (3 × 100 mL) and dried in a vacuum oven at 50 °C for 20 h to give 5 as a white solid (39.8 g, 94percent).
Reference: [1] Patent: US2003/229099, 2003, A1, . Location in patent: Page 269
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 10, p. 3887 - 3898
[3] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 23, p. 6492 - 6499
[4] Organic Process Research and Development, 2000, vol. 4, # 6, p. 613 - 614
[5] Journal of Medicinal Chemistry, 2007, vol. 50, # 19, p. 4585 - 4605
[6] Journal of Medicinal Chemistry, 2009, vol. 52, # 12, p. 3703 - 3715
  • 15
  • [ 76-83-5 ]
  • [ 33016-47-6 ]
Reference: [1] Synthetic Communications, 1987, vol. 17, # 2, p. 223 - 228
[2] Patent: US2002/86859, 2002, A1,
[3] Patent: US4332813, 1982, A,
  • 16
  • [ 76-83-5 ]
  • [ 71-00-1 ]
  • [ 35146-32-8 ]
Reference: [1] Polymer, 2015, vol. 69, p. 274 - 282
  • 17
  • [ 95383-91-8 ]
  • [ 76-83-5 ]
  • [ 75-78-5 ]
  • [ 35146-32-8 ]
Reference: [1] Journal of Organic Chemistry, 1982, vol. 47, # 7, p. 1324 - 1326
  • 18
  • [ 75-77-4 ]
  • [ 95383-91-8 ]
  • [ 76-83-5 ]
  • [ 58995-29-2 ]
  • [ 35146-32-8 ]
Reference: [1] Journal of Organic Chemistry, 1982, vol. 47, # 7, p. 1324 - 1326
  • 19
  • [ 76-83-5 ]
  • [ 31938-11-1 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 18, p. 5926 - 5933
[2] Angewandte Chemie - International Edition, 2014, vol. 53, # 1, p. 324 - 328[3] Angew. Chem., 2014, vol. 126, # 1, p. 337,1
[4] Tetrahedron, 2016, vol. 72, # 32, p. 4813 - 4820
  • 20
  • [ 76-83-5 ]
  • [ 21947-98-8 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 13, p. 2615 - 2618
[2] Patent: CN106432014, 2017, A,
  • 21
  • [ 76-83-5 ]
  • [ 107-96-0 ]
  • [ 27144-18-9 ]
YieldReaction ConditionsOperation in experiment
93% at 20℃; Trityl chloride (14.1 g, 50.6 mmol, 1.1 eq.) was dissolved in DCM(160 mL) and 3-mercaptopropionic acid (4 mL, 46 mmol, 1.0 eq) was added to the flask.Reaction was stirred at room temperature overnight during which the product precipitatedas a white solid. Reaction was filtered off and the white solid was washed extensively withDCM and then dried under high vacuum. The product was obtained in 93percent yield (14.8 g).1H-NMR (DMSO-d6): δ 7.18 – 7.39 (m, 15H, arom H), 2.28 (t, J = 7.2 Hz, 2H, -S-CH2-), 2.16 (t, J= 7.2 Hz, 2H, -CH2-CO2H); 13C-NMR (DMSO-d6): δ 172.7, 144.3, 129.1, 128.0, 126.7, 66.2,32.9, 26.7;
88% at 23℃; for 17 h; Triphenylmethyl chloride (2.7 g, 9.5 mmol, 1.0 equiv) was added to a stirred solution of 3-thiopropanoic acid (1.0 g, 9.5 mmol, 1.0 equiv) in N,N-dimethylformamide (15 mL) at 23° C.
The resulting colorless solution was stirred at 23° C. for 17 h.
The reaction mixture was diluted with water (300 mL) and extracted with diethyl ether (4*150 mL).
The combined organic layers were diluted with dichloromethane (100 mL) and methanol (100 mL) in order to dissolve all solids, dried (MgSO4), gravity filtered, and concentrated by rotary evaporation.
The residue was rinsed with dichloromethane and vacuum-filtered to afford the title compound as white crystals (2.9 g, 88percent): mp 205-208° C.; IR (KBr thin film) 3438 (w), 3024 (w), 2909 (w), 2742 (w), 2649 (w), 2565 (w), 1701 (s) cm-1; 1H NMR (300 MHz, DMSO-d6) δ 12.24 (br s, 1H), 7.20-7.40 (m, 15H), 2.28 (t, J=7 Hz, 2H), 2.16 (t, J=7 Hz, 2H); ESIMS m/z 347 ([M-H]-).
120 g at 25 - 30℃; for 6 h; To a solution of trityl chloride (100 gm) in toluene (500 ml), 3-mercapto propionic acid (41.9 gms) was added at 25-30°C and stirred it for 6 hours at 25-30°C. 500 ml of water was added to the reaction mixture at 25-30°C and stirred it for 15 minutes at the same temperature. Filtered the precipitated solid, washed with water and dried to get title compound. Yield: 120 gms; Melting Range 200-205°C.
Reference: [1] Chemistry and Physics of Lipids, 2002, vol. 115, # 1-2, p. 17 - 37
[2] Chemistry and Physics of Lipids, 2005, vol. 136, # 1, p. 23 - 46
[3] ChemMedChem, 2010, vol. 5, # 12, p. 2057 - 2064
[4] Angewandte Chemie - International Edition, 2018, vol. 57, # 24, p. 7023 - 7027[5] Angew. Chem., 2018, vol. 130, # 24, p. 7141 - 7145,5
[6] Synlett, 2018, vol. 29, # 19, p. 2582 - 2587
[7] ChemPlusChem, 2015, vol. 80, # 4, p. 704 - 714
[8] Patent: US2012/53146, 2012, A1, . Location in patent: Paragraph 0180; 0181
[9] Tetrahedron, 2009, vol. 65, # 7, p. 1257 - 1267
[10] Tetrahedron Letters, 1998, vol. 39, # 51, p. 9327 - 9330
[11] Chemical Communications, 2010, vol. 46, # 37, p. 6992 - 6994
[12] Tetrahedron, 1997, vol. 53, # 49, p. 16859 - 16866
[13] Bulletin de la Societe Chimique de France, 1924, vol. &lt;4&gt; 35, p. 388
[14] Helvetica Chimica Acta, 1996, vol. 79, # 7, p. 2023 - 2034
[15] Journal of Organic Chemistry, 2008, vol. 73, # 21, p. 8142 - 8153
[16] Patent: US2003/235916, 2003, A1, . Location in patent: Page 20
[17] International Journal of Pharmaceutics, 2010, vol. 396, # 1-2, p. 229 - 238
[18] Chemical Communications, 2013, vol. 49, # 45, p. 5177 - 5179
[19] Patent: WO2014/74218, 2014, A1, . Location in patent: Paragraph 00406-00408
[20] Patent: WO2017/68596, 2017, A1, . Location in patent: Page/Page column 25; 26
[21] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 11, p. 3039 - 3045
  • 22
  • [ 52-89-1 ]
  • [ 76-83-5 ]
  • [ 2799-07-7 ]
YieldReaction ConditionsOperation in experiment
89% at 20℃; for 48 h; L-Cysteine hydrochloride (100 g, 0.634 mol) and trityl chloride (270 g, 0.969 mol) were stirred in DMF (400 mL) for 2 days at room temperature. A 10percent sodium acetate solution (3.5 L) was then added dropwise and the white precipitate which formed was filtered and washed with distilled water. Afterward, the residue was stirred in acetone at 50° C. for 30 min after which it was cooled to 0° C. and filtered. The precipitate was washed with a little acetone and diethyl ether and dried in vacuo. S-Trityl-L-cysteine 1b (205 g, 89percent) was obtained as a white powder. 1b: m.p. 192° C. (decomp). 1H NMR (DMSO-d6) δ 2.45 (dd, 1H, J=9 Hz, 12 Hz), 2.58 (dd, 1H, J=4.4 Hz, 12 Hz), 2.91 (m, 1H), 7.22-7.36 (m, 15H); 13C NMR (75.5 MHz, DMSO-d6): δ 33.8, 53.7, 66.4, 127.1, 127.8, 128.1, 128.4, 129.5, 144.5, 168.4. This material was directly used in the next step without further purification.
89% With sodium acetate In N,N-dimethyl-formamide at 20℃; for 48 h; L-Cysteine hydro-chloride (100 g, 0.634 mol) and trityl chloride (270 g, 0.969 mol) were stirred in DMF (400 mL) for 2 days at room temperature. A 10percent sodium acetate solution (3.5 L) was then added dropwise and the white precipitate which formed was filtered and washed with distilled water. Afterward, the residue was stirred in acetone at 50 0C for 30 min after which it was cooled to 00C and filtered. The precipitate was washed with a little acetone and diethyl ether and dried in vacuo. S-Trityl-L-cysteine Ic (205 g, 89percent) was obtained as a white powder. Ic: m.p. 192 °C (decomp) ; 1H NMR (300 MHz, DMSCW5) δ 2.45 (dd, IH, J= 9 Hz, 12 Hz), 2.58 (dd, IH, J= 4.4 Hz, 12 Hz), 2.91 (m, IH), 7.22-7.36 (m, 15H); 13C NMR (75.5 MHz, DMSO- d6): δ 33.8, 53.7, 66.4, 127.1, 127.8, 128.1, 128.4, 129.5, 144.5, 168.4. This material was directly used in the next step without further purification.
78% at 20℃; for 48 h; Preparation 75: Synthesis of (R)-3-amino-4-tritylsulfanyl-butyric acid methyl ester hydrochloride; (Step 1); L-cysteine hydrochloride (5Og, 284.7mmol) was dissolved in N,N- dimethylformamide (200ml). Trityl chloride (119g, 427.0mmol) was added thereto, and the mixture was stirred for 48 h at room temperature. After completion of the reaction, 10percent sodium acetate (1.5L) was added. The mixture was filtered to give a solid, which was then added to acetone (1.5L), and stirred for 30 min at 50 °C . The insoluble solid was filtered, and dried to give a trityl compound (80g, Yield 78percent).
77% at 20℃; for 48 h; Synthetic Example 1; (R)-3-Mercapto-2-(5-methyl-4-phenyl-thiazoI-2-yIamino)-propionic acid; Step 1 : S-Trityl-L-cysteine falso known as (R)-2-amino-3- (tritylsulfanyl)propanoic acid); L-Cysteine hydrochloride (5.0 g, 31.7 mmol) and trityl chloride (13.5 g, 48.4 mmol) were stirred in DMF (20 ml) for 48 h at room temperature. A 10percent NaOAc solution (175 mL) was then added, and the precipitate was filtered and washed with water. Afterward, the residue was suspended in acetone and stirred at 50 °C for 30 min, then cooled and filtered. The residue was washed with acetone (cold) and diethyl ether. After drying 8.86 g (77percent) S-trityl-L-cysteine was obtained.

Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 4, p. 619 - 626
[2] Organic Letters, 2005, vol. 7, # 13, p. 2615 - 2618
[3] Patent: US7829709, 2010, B1, . Location in patent: Page/Page column 19-20
[4] Patent: WO2009/100431, 2009, A1, . Location in patent: Page/Page column 28
[5] Patent: WO2009/82152, 2009, A2, . Location in patent: Page/Page column 214
[6] Patent: WO2009/151744, 2009, A1, . Location in patent: Page/Page column 93
[7] Chemical Communications, 2009, # 4, p. 407 - 409
[8] Acta Chemica Scandinavica (1947-1973), 1959, vol. 13, p. 383
[9] Journal of the American Chemical Society, 1962, vol. 84, p. 3887 - 3897
  • 23
  • [ 76-83-5 ]
  • [ 2799-07-7 ]
YieldReaction ConditionsOperation in experiment
76.15% at 60 - 65℃; for 8 h; The compound L-cysteine hydrochloride (10 g, 63.45 mmol)Was dissolved in N, N-dimethylformamide (120 ml)Triphenylchloromethane (19.46 g, 69.795 mmol) was added,Heated to 60-65 ° C,Reaction for 8 hours,TLC detection reaction is completed,Cooled to room temperature,A 10percent sodium acetate solution (300 ml) was added,Precipitation of white solid,filter,The residue was washed with pure water (300 ml)Then washed with acetone (200 ml)dry,The product was a white solid (17.56 g, yield: 76.15percent).
Reference: [1] Patent: CN106432014, 2017, A, . Location in patent: Paragraph 0096; 0097; 0098; 0099; 0142; 0143; 0144; 0145
  • 24
  • [ 76-83-5 ]
  • [ 2799-07-7 ]
Reference: [1] Organic Letters, 2006, vol. 8, # 15, p. 3215 - 3217
  • 25
  • [ 52-90-4 ]
  • [ 76-83-5 ]
  • [ 2799-07-7 ]
Reference: [1] Patent: WO2007/9944, 2007, A1, . Location in patent: Page/Page column 31-32
[2] Patent: WO2007/9944, 2007, A1, . Location in patent: Page/Page column 30-31
  • 26
  • [ 52-89-1 ]
  • [ 76-83-5 ]
  • [ 2799-07-7 ]
  • [ 27686-50-6 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1956, p. 698
  • 27
  • [ 76-83-5 ]
  • [ 26988-61-4 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1956, p. 698
[2] Bulletin de la Societe Chimique de France, 1956, p. 698
  • 28
  • [ 637-31-0 ]
  • [ 76-83-5 ]
  • [ 4486-05-9 ]
Reference: [1] Chemische Berichte, 1919, vol. 52, p. 897
  • 29
  • [ 76-83-5 ]
  • [ 103057-10-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2006, vol. 4, # 9, p. 1768 - 1784
[2] Patent: CN106632268, 2017, A,
[3] Patent: US5891889, 1999, A,
[4] Patent: WO2018/191146, 2018, A1,
  • 30
  • [ 76-83-5 ]
  • [ 135248-89-4 ]
  • [ 103213-32-7 ]
Reference: [1] Protein and Peptide Letters, 2014, vol. 21, # 12, p. 1257 - 1264
  • 31
  • [ 52-90-4 ]
  • [ 82911-69-1 ]
  • [ 76-83-5 ]
  • [ 103213-32-7 ]
Reference: [1] Synlett, 2017, vol. 28, # 15, p. 1923 - 1928
  • 32
  • [ 76-83-5 ]
  • [ 120568-11-8 ]
  • [ 124750-53-4 ]
YieldReaction ConditionsOperation in experiment
95.2%
Stage #1: With sodium hydroxide In water; acetone at 40℃; for 1 h;
Dissolve compound 2 (200 g) with stirring at 40°C700mL of acetone,Aqueous sodium hydroxide solution (40.67 g sodium hydroxide dissolved in 160 mL water) is added,Continue stirring for 1h,A solution of triphenylchloromethane in acetone (270.8 g of triphenylmethyl chloride dissolved in 800 mL of acetone) was initially added dropwise.The solid was added dropwise and gradually evolved into a white turbid liquid.The reaction was monitored by TLC until it was completely filtered off and washed with water to give a solid as intermediate 3.The solid was blow dried at 50°C to give white intermediate 3 (385 g), yield: 95.2percent, HPLC: 99.44percent.
67% With dmap; triethylamine In dichloromethane at 20℃; General procedure: A solution of the appropriate tetrazole 1 (10.0 mmol) in CH2Cl2 (5mL) was added to a solution of TrCl (3.1 g, 11.0 mmol), Et3N (2.5mL, 17.6 mmol), and DMAP (92 mg, 0.4 mmol) in CH2Cl2 (10 mL)at r.t., and the mixture was stirred overnight. The reaction was thenquenched with H2O (5 mL) and the mixture was extracted withEtOAc (3 × 15 mL). The organic phases were combined, washedwith brine (5 mL), dried (Na2SO4), and concentrated at 15 Torr. Theresidue was purified by column chromatography (deactivated silicagel, hexane–EtOAc) to give the expected tetrazoles 1a–f and 1i–l.For the preparation of the ditritylated compound 1g, the amounts ofthe reagents and solvents used were double those indicated above.
67% With dmap; triethylamine In dichloromethane at 20℃; General procedure: A solution of the corresponding tetrazole (10.0 mmol) in CH2Cl2 (5 mL) was added to a solution of trityl chloride (3.1 g, 11.0 mmol),triethylamine (2.5 mL, 17.6 mmol) and 4-(dimethylamino)pyridine (92 mg, 0.4 mmol) in CH2Cl2 (10 mL) at room temperature and themixture was stirred overnight. The reaction was then quenched with water (5 mL) and extracted with ethyl acetate (3 15 mL) and thecombined organic phases were washed with brine (5 mL) and dried over sodium sulfate. After evaporation of the solvents (15 Torr),the resulting residue was purified by column chromatography (deactivated silica gel, hexane/ethyl acetate) affording the expectedtetrazoles 1a-1f and 1i-1l.For the preparation of the double tritylated compound 1g the amounts of the reagents and solvent used were double the ones indicatedabove. Compound 1g was separated by column chromatography [deactivated silica gel, hexane/ethyl acetate]. The correspondingphysical, spectroscopic and analytical data for the tritylated tetrazoles follow.
67% With dmap; triethylamine In dichloromethane at 20℃; General procedure: A solution of the corresponding tetrazole (10.0 mmol) in CH2Cl2 (5 mL) was added to a solution of trityl chloride (3.1 g, 11.0 mmol), triethylamine (2.5 mL, 17.6 mmol) and 4-(dimethylamino)pyridine (92 mg, 0.4 mmol) in CH2Cl2 (10 mL) at r.t. and the mixture was stirred overnight. The reaction was then quenched with H2O (5 mL) and extracted with EtOAc (3 × 15 mL) and the combined organic phases were washed with brine (5 mL) and dried over sodium sulfate. After evaporation of the solvents (15 torr), the resulting residue was purified by column chromatography (deactivated silica gel; hexane–EtOAc) to afford the expected tetrazole 1a–f,i–l. For the preparation of the double tritylated compound 1g, the amounts of the reagents and solvent used were double those indicated above. Compound 1g was separated by column chromatography [deactivated silica gel; hexane–EtOAc].

Reference: [1] Patent: WO2013/78237, 2013, A1, . Location in patent: Page/Page column 111; 112
[2] Patent: CN107935957, 2018, A, . Location in patent: Paragraph 0020; 0040-0042
[3] Synthetic Communications, 2008, vol. 38, # 20, p. 3577 - 3581
[4] Journal of Chemical Sciences, 2011, vol. 123, # 4, p. 393 - 401
[5] Archiv der Pharmazie, 2016, vol. 349, # 12, p. 934 - 943
[6] Synthesis (Germany), 2014, vol. 46, # 15, p. 2065 - 2070
[7] Synlett, 2015, vol. 26, # 17, p. 2399 - 2402
[8] Synthesis (Germany), 2016, vol. 48, # 15, p. 2455 - 2460
[9] Journal of Chemical Sciences, 2014, vol. 126, # 1, p. 205 - 212
[10] Journal of Chemical Sciences, 2014, vol. 126, # 1, p. 205 - 212
[11] Patent: EP2162441, 2016, B1, . Location in patent: Paragraph 0219
  • 33
  • [ 1461-22-9 ]
  • [ 76-83-5 ]
  • [ 124750-53-4 ]
Reference: [1] Patent: US5254546, 1993, A,
[2] Patent: US5254546, 1993, A,
  • 34
  • [ 114772-53-1 ]
  • [ 76-83-5 ]
  • [ 124750-53-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 8, p. 2370 - 2378
[2] Journal of Organic Chemistry, 1991, vol. 56, # 7, p. 2395 - 2400
[3] Farmaco, 1997, vol. 52, # 3, p. 147 - 155
  • 35
  • [ 7646-93-7 ]
  • [ 96042-30-7 ]
  • [ 76-83-5 ]
  • [ 124750-53-4 ]
Reference: [1] Patent: US5270317, 1993, A,
  • 36
  • [ 76-83-5 ]
  • [ 124750-53-4 ]
Reference: [1] Patent: US5276048, 1994, A,
  • 37
  • [ 76-83-5 ]
  • [ 150437-97-1 ]
  • [ 124750-53-4 ]
Reference: [1] Patent: US5210211, 1993, A,
  • 38
  • [ 76-83-5 ]
  • [ 124750-53-4 ]
Reference: [1] Patent: EP2162441, 2016, B1, . Location in patent: Paragraph 0219
  • 39
  • [ 2302-25-2 ]
  • [ 76-83-5 ]
  • [ 87941-55-7 ]
YieldReaction ConditionsOperation in experiment
72% With triethylamine In tetrahydrofuran; dichloromethane at 20℃; for 1 h; To a single-necked flask was added 4-bromoimidazole (30 g, 205 mmol)Dichloromethane: tetrahydrofuran = 1: 1,And triphenylchloromethane (62 g, 226 mmol)Triethylamine (29 ml) was added with stirring at room temperature,Continue stirring for 1 h, add water and 1N hydrochloric acid,Adding methylene chloride extraction,The organic layers were combined and dried over anhydrous sodium sulfate,Spin dry dichloromethane to give compound 7 (61g, 72percent yield).
Reference: [1] Journal of Medicinal Chemistry, 2010, vol. 53, # 4, p. 1712 - 1725
[2] Patent: CN106256830, 2016, A, . Location in patent: Paragraph 0044; 0045; 0055; 0056; 0057
  • 40
  • [ 2302-25-2 ]
  • [ 76-83-5 ]
  • [ 76-84-6 ]
  • [ 87941-55-7 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1989, p. 95 - 99
  • 41
  • [ 71759-89-2 ]
  • [ 76-83-5 ]
  • [ 96797-15-8 ]
YieldReaction ConditionsOperation in experiment
94% With triethylamine In N,N-dimethyl-formamide at 20℃; for 24 h; To a solution of 3 (3.5 g,18.0 mmol) in DMF (70 mL) was added TEA (3.0 mL, 21.7 mmol) andtrityl chloride (5.5 g, 19.7 mmol). After stirring at 20 C for 24 h, thesolution was poured into water. The solid was filtered to yield thecrude compound that was purified by flash column chromatographyon silica gel to afford 4 as a white solid (7.4 g, 94.0percent). Mp148e150 C. 1H NMR (300 MHz, Chloroform-d) d(ppm) 6.9 (m, 1H),7.0e7.2 (m, 6H), 7.25e7.4 (m, 10H). MS (EI) m/z 437.1 [MH].
94% With triethylamine In N,N-dimethyl-formamide at 20℃; for 24 h; 2 (3.5 g, 18.0 mmol) was dissolved in DMF (70 mL),Triethylamine (3.0 mL, 21.6 mmol) was added dropwise,Trityl chloride (5.5 g, 19.7 mmol) was added,After 24 hours at room temperature,Poured into 200mL water,Precipitation of a large number of solids,Suction filtration,Ether filtered and washed,Drying gives a white solid,Yield 94.0percent
93% With triethylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 48 h; To a solution of 4-iodoimidazole (50 g, 258 mmoles) in DMF (500 ml) was added triethyl amine (37.7 ml, 270.6 mmoles) and than triphenylmethyl chloride (69.7 g, 250 mmoles). After stirring at room temperature for 48 hours, the solution was poured into ice water (2.5 L). The solid was filtered and pumped on for several hours to yield the crude compound. Ethyl ether (200 ml) was added to the crude compound and the solution was filtered to yield 4-IODO-1-TRITYL-LH-IMIDAZOLE (104.1, 93percent) as a white solid. ME (437)
93% With triethylamine In DMF (N,N-dimethyl-formamide) at 20℃; for 48 h; To a solution of 4-iodoimidazole (50 g, 258 mmoles) in DMF (500 ML) was added triethyl amine (37.7 ml, 270.6 mmoles) and than triphenylmethyl chloride (69.7 g, 250 mmoles). After stirring at room temperature for 48 hours, the solution was poured into ice water (2.5 L). The solid was filtered and pumped on for several hours to yield the crude compound. Ethyl ether (200 ml) was added to the crude compound and the solution was filtered to yield 4-IODO-1-TRITYL-LH-IMIDAZOLE (104.1, 93percent) as a white solid. MH+ (437)
93% With triethylamine In dichloromethane at 25℃; for 17 h; Cooling with ice; Inert atmosphere After dissolving 4-iodo -1Himidazole(compound 1) (1.9g, 10mmol) in dichloromethane (40mL), under ice-cooling,triethylamine (2.1mL, 15mmol), trityl chloride (3.4g, 12mmol) It was added, under argon, andstirred for 17 hours at room temperature (25 ° C). After completion of the reaction, water wasadded, and the mixture was extracted twice with dichloromethane. The combineddichloromethane layers were dried anhydrous sodium sulfate and concentrated under reducedpressure, silica and the resulting crude product was gel column chromatography (eluent:chloroform / n-hexane = 1/1 → chloroform) at Purification, Compound 2 It was obtained (4.1g,9.3mmol, 93percent yield).
93% With triethylamine In dichloromethane at 25℃; for 17 h; Inert atmosphere 4-Iodo-1H-imidazole (Compound 25, manufactured by Wako Pure Chemical Industries, Ltd.) (1.9 g, 10 mmol) was dissolved in dichloromethane (40 mL)Triethylamine (2.1 mL, 15 mmol) and trityl chloride (3.4 g, 12 mmol) were added and the mixture was stirred at room temperature (25 ° C.) for 17 hours under an argon gas atmosphere. After completion of the reaction, water was added and the mixture was extracted twice with dichloromethane. The combined dichloromethane layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained crude product was purified by silica gel column chromatography (eluent: chloroform / n-hexane = 1/1 → chloroform) to obtain compound 26 (4.1 g, 9.3 mmol, yield 93percent).
93% With triethylamine In dichloromethane at 25℃; for 17 h; Inert atmosphere 4-iodo-1H-imidazole (Compound 13, manufactured by Wako Pure Chemical Industries, Ltd.) (1.9 g, 10 mmol) was dissolved in dichloromethane (40 mL)below freezing,Triethylamine (2.1 mL, 15 mmol),Trityl chloride (3.4 g, 12 mmol) was added,Under an argon gas atmosphere,And the mixture was stirred at room temperature (25 ° C.) for 17 hours.After completion of the reaction,Add water,Extraction was carried out twice with dichloromethane.The combined dichloromethane layer was dried over anhydrous sodium sulfate, concentrated under reduced pressure,The obtained crude product was purified by silica gel column chromatography (eluent (volume ratio): chloroform / n-hexane = 1/1 → chloroform) to obtain Compound 14 (4.1 g, 9.3 mmol, yield 93percent).
92% at 20℃; for 24 h; To a solution of 4-iodoimidazole (1 eq) in DMF at room temperature was added triphenylmethyl chloride (1.2 eq). After stirring at room temperature for 24 h, the solution was poured into ice water and left stirring for 30 min. The solid was filtered and pumped on for several hours to yield the crude compound. Ethyl ether was added to the crude compound and the solution was filtered to yield 4-iodo-1- TRITYL-LH-IMIDAZOLE (92percent) as a white solid. MH+ (437).
92%
Stage #1: With triethylamine In N,N-dimethyl-formamide at 0℃; for 0.166667 h;
Stage #2: at 20℃; for 16 h;
At 0° C., to a solution of 4-iodo-1H-imidazole (5 g, 25.8 mmol) in DMF (100 mL) was added triethylamine (3.13 g, 30.9 mmol) slowly. After stirring for additional 10 min at 0° C., the reaction mixture was added by TrtCl (7.17 g, 25.7 mmol). The resulting solution was then stirred at room temperature for 16 h. The reaction mixture was poured into 1 L water. A white solid precipitated out and were collected by filtration. The solid was rinsed with MeOH (50 mL×2) and Et2O (50 mL×3), and then dried in vacuo to yield 4-iodo-1-(triphenylmethyl)-1H-imidazole as white solid (10.4 g, 92percent).
90% at 0 - 20℃; 4-lodo-1tf-imidazole (2.8g, 14.6mmol) and trityl chloride (5.Og, 20.5mmol) were dissolved in λ/,λ/-dimethylacetamide (45mL). The solution was cooled to 0"C and triethylamine (4mL, 29.2mmol) added slowly. The reaction mixture was slowly warmed to room temperature. After 48 hours the solution was poured to water(15OmL). The solid was filtered, washed with water, hexane and dried to give a white solid (5.7g) with a yield of 90percent. The product was pure enough for the next step reaction without further purification.
88.9% With triethylamine In N,N-dimethyl-formamide at 20℃; for 48 h; 4-iodo-1H-imidazole (20 g, 103 mmoles) was dissolved in DMF (100 mL) then triethylamine (15.1 mL, 108 mmoles) and triphenylmethyl chloride (27.8 g, 100 mmoles). The reaction mixture was stirred at room temperature for 48 h, then poured into ice water (500 mL), and then evaporated to dryness, and filtered, and dried to give white crystals of 4-iodo-1-triphenylmethyl-1H-imidazole (40 g, 91.7 mmol, 88.9percent).
81% With triethylamine In tetrahydrofuran at 70℃; for 3 h; Inert atmosphere Triethylamine (36.0 mL, 258 mmol) was added to a mixture of 4-iodoimidazole (24.8 g, 128 mmol) and trityl chloride (39.2 g, 141 mmol) in THF (275 mL), the resulting mixture was heated at 70 °C for 3 hours under nitrogen. The reaction was cooled to 45 °C and filtered to remove thesuspended white solid (Et3N.HCI). The filtrate was concentrated in vacuo, dissolved in DCM (500 mL) and washed with 5 wtpercent aq. sodium thiosulfate solution (300 mL). The aqueous layer was extracted with DCM (150 mL). The combined organics were dried over Na2SO4, filtered and concentrated in vacuo to afford an off white solid. Hot filtration was carried out with methanol (500 ml) at 90°C to afford a white solid characterised as 4-iodo-1-trityl-imidazole (45.2 g, 104 mmol, 81percentyield). 1H NMR (CDCI3, 400 MHz) O: 7.36-7.44 (m, 9H), 7.28-7.32 (m, 1H), 7.10-7.15 (m, 6H), 6.94 (5, 1 H). LCMS purity >95percent, [M+H] = 437.0, 4.47 mm (analytical long).
71% With triethylamine In tetrahydrofuran at 80℃; 4-Iodoimidazole (0101-1) (10.0 g, 51.6 mmol, 1.0 eq.)Dissolved in 150 ml of tetrahydrofuran,Triphenylmethyl chloride (17.2 g, 61.7 mmol, 1.2 equivalents) andTriethylamine (14.5 ml, 10.4 mmol, 2.0 eq),Heat to 80°C and react overnight.Cooled to room temperature, concentrated under reduced pressure, added ethyl acetate, washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. Methanol and a small amount of dichloromethane were added and stirred for half an hour. The solid was collected by suction, washed twice with methanol, and vacuum dried. ,4-Iodo-1-trityl-1H-imidazole (16 g, yield: 71percent) was obtained as a white solid.
66% With triethylamine In N,N-dimethyl-formamide at 20℃; for 14 h; After dissolving 4-iodo-1H-imidazole (3.0 g, 0.015 mol) and triphenylmethyl chloride (6.0 g, 0.021 mol) in anhydrous N, N-dimethylformamide (50 mL) Deg.] C, triethylamine (7.2 mL, 0.052 mol) was added slowly, and the mixture was stirred at room temperature for 14 hours. The reaction mixture was concentrated, and then distilled water (100 mL) was added thereto. After stirring at room temperature for 20 minutes, the solid was filtered The filtrate was washed with distilled water and diethyl ether to give the title compound 60-a (4.4 g, 66percent) as a white solid.
59% With triethylamine In water; N,N-dimethyl-formamide Preparation 72
4-Iodo-1-triphenylmethyl-1H-imidazole
To 4-iodo-1H-imidazole (Preparation 71, 3.0 g, 15.3 mmol) in N,N-dimethylformamide (25 ml) was added triphenylmethyl chloride (4.72 g, 16.9 mmol) and then triethylamine (2.5 ml, 18.4 mmol).
After stirring at room temperature for 2.5 h, water (200 ml) was added and the reaction mixture was filtered and washed with water.
The crude solid was chromatographed on silica gel eluding with hexane:ethyl acetate (5:1 and then 2:1).
The material was then recrystallized from hexane and dichloromethane to give the title compound as a white solid (4.0 g, 59percent).
NMR (CDCl3, selected data for the free base: 6.9 (m, 1H), 7.0-7.2 (m, 6H), 7.25-7.4 (m, 10H).
MS (TSP): M/Z (MH+): 436.3; C22H17129IN2+H requires 437.1.
55.57% With triethylamine In tetrahydrofuran at 70℃; for 3 h; 4-iodoimidazole (5.38g, 27.72mmol) was dissolved in THF (86ml_). Trityl chloride, (8.5g, 30.49mmol) and triethylamine (7.73ml_, 55.44mmol) were added and the reaction was heated at 70 °C. After 3 h, TLC showed that the reaction had gone to completion. Therefore, the reaction mixture was allowed to cool to 45 C and filtered to remove the suspended white solid. The filtrate was concentrated, redissolved in DCM (300 mL) and washed with 5 wtpercent aq. sodium thiosulfate solution (300 mL), which was back-extracted with DCM (150 mL). The organics were combined, dried over sodium sulfate, filtered and concentrated to yield the crude product. The white solid was taken up in EtOAc (300ml) and heated to reflux for 30 minutes. The mixture was cooled and the solid was obtained by vacuum filtration. The white solid was dried in the vacuum oven for 3 hours affording 4- iodo-1 -trityl-imidazole (6.721 g, 15.40mmol, 55.57percent yield). MS Method 2: RT 2.08 min, ES+ m/z 459 [M+Na]+ H NMR (400MHz, DMSO) δ/ppm: 7.35-7.40 (m, 10H), 7.06-7.1 1 (m, 7H).

Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 57 - 59
[2] European Journal of Medicinal Chemistry, 2017, vol. 140, p. 293 - 304
[3] Patent: CN107501272, 2017, A, . Location in patent: Paragraph 0085; 0086; 0091; 0092
[4] Patent: WO2004/96822, 2004, A2, . Location in patent: Page 262
[5] Patent: WO2004/96823, 2004, A2, . Location in patent: Page 44; 45
[6] Patent: JP2015/93833, 2015, A, . Location in patent: Paragraph 0057; 0058
[7] Patent: JP2015/93831, 2015, A, . Location in patent: Paragraph 0016; 0100; 0101
[8] Patent: JP2015/110563, 2015, A, . Location in patent: Paragraph 0016; 0078; 0079
[9] Patent: WO2004/96822, 2004, A2, . Location in patent: Page 239; 240
[10] Patent: US2016/75711, 2016, A1, . Location in patent: Paragraph 0216-0217
[11] Patent: WO2009/93981, 2009, A1, . Location in patent: Page/Page column 96
[12] Patent: CN108203438, 2018, A, . Location in patent: Paragraph 0142; 0143; 0144; 0145
[13] Patent: WO2016/59412, 2016, A1, . Location in patent: Paragraph 00200; 00201
[14] Synthesis, 1994, # 7, p. 681 - 682
[15] Patent: CN107383024, 2017, A, . Location in patent: Paragraph 0112
[16] Patent: KR101798840, 2017, B1, . Location in patent: Paragraph 1139-1142
[17] Journal of Medicinal Chemistry, 2008, vol. 51, # 10, p. 2944 - 2953
[18] Patent: US6313312, 2001, B1,
[19] Patent: WO2016/55786, 2016, A1, . Location in patent: Paragraph 00231
[20] Journal of Medicinal Chemistry, 1996, vol. 39, # 15, p. 3001 - 3013
[21] Journal of Organic Chemistry, 2007, vol. 72, # 10, p. 3741 - 3749
[22] Patent: US5932606, 1999, A,
[23] Patent: US2002/19527, 2002, A1,
  • 42
  • [ 71759-89-2 ]
  • [ 60-29-7 ]
  • [ 76-83-5 ]
  • [ 96797-15-8 ]
Reference: [1] Patent: US2003/125266, 2003, A1,
  • 43
  • [ 50-99-7 ]
  • [ 76-83-5 ]
  • [ 54325-28-9 ]
YieldReaction ConditionsOperation in experiment
88% at 80℃; for 4 h; To glucose (5g; 0.0277 mole) as a suspension in pyridine (50 mL) was added trityl chloride and stirred at 8O0C for about 4 hours. The completion of the reaction was checked by TLC using dichloromethane: methanol (85:15). The reaction was quenched with water (100 mL) and extracted with dichloromethane (150 ml x 2). The organic layer was washed with saturated solution of sodium bicarbonate and water, dried over anhydrous sodium sulfate and the solvent was removed by rotory evaporator. Trityl Chloride and pyridine were removed by triturating with hexane: diethyl ether mixture (10OmL) to afford the desired product (10.3 g; 88percent), LC-MS gave the M+ at 446 amu in accordance with the structure.
Reference: [1] Patent: WO2007/54977, 2007, A2, . Location in patent: Page/Page column 21
[2] Patent: KR101595939, 2016, B1, . Location in patent: Paragraph 0102-0103
  • 44
  • [ 2280-44-6 ]
  • [ 76-83-5 ]
  • [ 54325-28-9 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 40, p. 10042 - 10053
[2] Tetrahedron Letters, 1989, vol. 30, # 1, p. 35 - 38
[3] Carbohydrate Research, 1995, vol. 279, p. 281 - 291
[4] Tetrahedron Letters, 1996, vol. 37, # 23, p. 4015 - 4018
[5] Chemical and Pharmaceutical Bulletin, 1997, vol. 45, # 4, p. 626 - 630
[6] Carbohydrate Research, 1997, vol. 303, # 1, p. 1 - 15
[7] Carbohydrate Research, 1997, vol. 301, # 3-4, p. 123 - 143
[8] Journal of the American Chemical Society, 1999, vol. 121, # 51, p. 12196 - 12197
[9] Organic Letters, 2009, vol. 11, # 4, p. 939 - 942
[10] Journal of Medicinal Chemistry, 2011, vol. 54, # 5, p. 1481 - 1489
[11] Molecules, 2013, vol. 18, # 9, p. 11198 - 11218
[12] Journal of Labelled Compounds and Radiopharmaceuticals, 2014, vol. 57, # 14, p. 737 - 743
[13] Organic and Biomolecular Chemistry, 2017, vol. 15, # 23, p. 5025 - 5032
[14] Patent: CN107286207, 2017, A, . Location in patent: Paragraph 0017
  • 45
  • [ 492-62-6 ]
  • [ 76-83-5 ]
  • [ 54325-28-9 ]
Reference: [1] Patent: WO2006/115312, 2006, A1, . Location in patent: Page/Page column 20
[2] Patent: US2008/39421, 2008, A1, . Location in patent: Page/Page column 4; 8
  • 46
  • [ 76-83-5 ]
  • [ 76587-61-6 ]
Reference: [1] Synlett, 2017, vol. 28, # 15, p. 1923 - 1928
  • 47
  • [ 76-83-5 ]
  • [ 57044-25-4 ]
  • [ 129940-50-7 ]
YieldReaction ConditionsOperation in experiment
73% With dmap; triethylamine In dichloromethane at 20℃; Inert atmosphere; Cooling Trityl protected glycidol derivative 401 was prepared as described previously (Schweizer, et al., Synthesis 2007, 3807-3814; which is incorporated herein by reference.) A solution of (/?)-glycidol (5.0 g, 61 mmol) in CH2Cl2 (30 mL) was added by syringe to a stirred solution of trityl chloride (18.6 g, 66.8 mmol) and triethylamine (16.9 mL, 122 mmol) in CH2Cl2 (67 mL) in an ice bath under argon. DMAP (742 mg, 6.08 mmol) was added to the reaction mixture following addition of the glycidol. The reaction was allowed to warm to room temperature. After 14 hours, the reaction mixture was diluted with 300 mL saturated aqueous NH4CI. The mixture was further diluted to ~ 1 L with water to dissolve precipitated salts. The product was extracted from the quenching solution with Et2O (3 x); combined ethereal layers were washed with brine, dried over MgSO4, filtered through paper, and concentrated by rotary evaporation to a white solid. The crude product was purified by recrystallization from boiling MeOH (200 mL) affording the desired product 401 (14.1 g, 73percent) as white crystals. NMR analysis of this material was consistent with that reported in the literature. (Schweizer, et al., Synthesis 2007, 3807-3814.)
Reference: [1] Synthesis, 2007, # 24, p. 3807 - 3814
[2] Tetrahedron Letters, 2000, vol. 41, # 33, p. 6323 - 6326
[3] Journal of Organic Chemistry, 2003, vol. 68, # 8, p. 3026 - 3042
[4] Journal of Organic Chemistry, 2013, vol. 78, # 11, p. 5172 - 5183
[5] Patent: WO2010/53572, 2010, A2, . Location in patent: Page/Page column 163
[6] ACS Chemical Neuroscience, 2018,
[7] Tetrahedron Letters, 1994, vol. 35, # 20, p. 3243 - 3246
[8] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1994, # 16, p. 2229 - 2236
[9] Journal of Organic Chemistry, 1998, vol. 63, # 6, p. 1961 - 1973
[10] Tetrahedron Letters, 1999, vol. 40, # 12, p. 2371 - 2374
[11] Patent: WO2006/14429, 2006, A2, . Location in patent: Page/Page column 11; figure 3
  • 48
  • [ 76-83-5 ]
  • [ 60456-23-7 ]
  • [ 129940-50-7 ]
Reference: [1] Patent: US6448422, 2002, B1,
  • 49
  • [ 616-91-1 ]
  • [ 76-83-5 ]
  • [ 27486-87-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 7, p. 2209 - 2218
[2] Tetrahedron Letters, 1997, vol. 38, # 12, p. 2149 - 2152
[3] Liebigs Annales, 1996, # 5, p. 841 - 843
[4] Patent: WO2017/60420, 2017, A1, . Location in patent: Page/Page column 34; 35; 36
[5] RSC Advances, 2018, vol. 8, # 5, p. 2818 - 2823
  • 50
  • [ 73746-45-9 ]
  • [ 76-83-5 ]
  • [ 157255-72-6 ]
Reference: [1] Chemical Communications, 2011, vol. 47, # 48, p. 12855 - 12857
[2] Synthesis, 1994, # 7, p. 681 - 682
[3] Patent: US2010/22598, 2010, A1, . Location in patent: Page/Page column 27-28
[4] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 1, p. 43 - 47
  • 51
  • [ 73746-45-9 ]
  • [ 76-83-5 ]
  • [ 157255-72-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 1, p. 282 - 293
  • 52
  • [ 3469-69-0 ]
  • [ 76-83-5 ]
  • [ 191980-54-8 ]
Reference: [1] Synthesis, 1997, # 5, p. 563 - 566
[2] Bioorganic and medicinal chemistry, 2001, vol. 9, # 12, p. 3243 - 3253
[3] Patent: US2015/329492, 2015, A1, . Location in patent: Sheet 1/5
[4] Journal of the American Chemical Society, 2018, vol. 140, # 20, p. 6383 - 6390
[5] MedChemComm, 2014, vol. 5, # 1, p. 72 - 81
[6] Patent: US6528510, 2003, B1,
  • 53
  • [ 76-83-5 ]
  • [ 195053-92-0 ]
Reference: [1] Journal of Biological Inorganic Chemistry, 2016, vol. 21, # 5-6, p. 777 - 792
[2] Patent: EP3000482, 2016, A1,
  • 54
  • [ 76-83-5 ]
  • [ 123-08-0 ]
  • [ 892112-24-2 ]
YieldReaction ConditionsOperation in experiment
75% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 6 h; General procedure: The 4-hydroxybenzaldehyde 4 (0.8 g, 6.5 mmol) was reacted with 4-monometoxytriphenylmethyl (1.0 g, 3.2 mmol) in 10 mL of anhydrous DCM in the presence of DIEA (2.2 mL, 12.9 mmol). After 6 h at r.t., the reaction was quenched by dilution with DCM (100 mL), and the organic phase was washed three times with a solution of 0.1 M NaOH (3×100 mL). The organic phase was dried with MgSO4, and then the solvent was removed under vacuum. The crude material was then purified on a column of silica gel (70 g) suspended in hexane/EtOAc 70:30 (v/v) with 1percent of TEA, leading to product 5 (1.05 g, 82percent). 1H NMR (400 MHz, 25°C, δ, ppm in CDCl3): δ 9.76 (s, 1H), 7.57–7.25 (complex signals, 14H), 6.86 (d, J=8.5 Hz, 2H), 6.82 (d, J=8.0 Hz, 2H), 3.77 (s, 3H). 13C NMR (100 MHz, 25°C, δ, ppm in CDCl3): δ 190.7, 161.9, 158.7, 143.8, 134.9, 130.6, 130.2, 128.3, 127.8, 127.3, 120.3, 113.1, 91.1, 55.0. Product 5 (1.05 g, 2.66 mmol) was subsequently treated with 0.25 g of NaBH4 (6.60 mmol) in THF (10 mL) for 6 h at r.t. The mixture was diluted with DCM (3×100 mL), and the organic phase was washed three times with water (100 mL). The organic phase was dried with MgSO4, and then the solvent was removed under vacuum. The crude solid thus obtained was purified on a column of silica gel (70 g) suspended in hexane/EtOAc 60:40 (v/v) with 1percent of TEA. From the column was recovered 0.845 g of clean desired product 6 (2.13 mmol, 80percent). 1H NMR (400 MHz, 25°C, δ, ppm in CDCl3): δ 7.49 (d, J=6.0 Hz, 4H), 7.37–7.22 (complex signals, 8H), 6.98 (d, J=7.2 Hz, 2H), 6.79 (d, J=7.2 Hz, 2H), 6.70 (d, J=6.8 Hz, 2H), 4.45 (s, 2H), 3.75 (s, 3H). 13C NMR (100 MHz, 25°C, δ, ppm in CDCl3): δ 158.4, 155.8, 144.5, 135.6, 133.3, 130.4, 128.6, 127.6, 127.4, 126.9, 120.6, 112.8, 90.0, 64.8, 55.0. Then, 0.40 g (1.01 mmol) of product 6 was reacted with N,N-diisopropyldichlorophosphoramidite (124 μL, 0.67 mmol) in the presence of DIEA (348 μL, 2.68 mmol) in DCM (7 mL). After 1.5 h, the reaction was quenched by dilution with DCM, and the organic phase was washed three times with cold water. The organic phase was dried with MgSO4 and the solvent removed under vacuum. The material was purified with column chromatography of silica gel in hexane/EtOAc 85:15 (v/v) with 2percent of TEA. From the column was recovered 0.74 g of clean desired product (1, 87percent).
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 10, p. 2979 - 2988
[2] Tetrahedron Letters, 2017, vol. 58, # 12, p. 1227 - 1229
  • 55
  • [ 269410-08-4 ]
  • [ 76-83-5 ]
  • [ 863238-73-7 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 1, p. 211 - 217
  • 56
  • [ 76-83-5 ]
  • [ 863238-73-7 ]
Reference: [1] Tetrahedron Letters, 2016, vol. 57, # 8, p. 895 - 898
  • 57
  • [ 76-83-5 ]
  • [ 139481-59-7 ]
  • [ 139481-72-4 ]
YieldReaction ConditionsOperation in experiment
94% With triethylamine In dichloromethane at 15 - 23℃; for 3.5 h; Flow reactor; Large scale I. Candesartan (10kg) and methylene chloride (100kg) were added to the reactor, and the temperature was lowered to 15°C. Triethylamine (4.5kg) was slowly added dropwise; after the addition was completed, the temperature of the reaction system was raised to 23°C. Triphenylchloromethane (7kg) was added in portions; after the addition, the reaction system temperature was maintained at 23°C for 3.5 hours; TLC monitoring (developer dichloromethane:methanol = 10:1 (V/V),Rf = 0.78) After the reaction is complete, add 0.1 mol/L HCl 30L (system pH = 5.4) at a time, add 5L 9mol/L HCl slowly to pH = 2.2, and separate the aqueous and organic layers by standing. 60L for the organic layer. The saturated saline solution was washed, transferred to a vacuum vessel, and the dichloromethane was recovered under reduced pressure.The residue in the kettle was added with 65 L of ethanol, and the temperature was raised to 45° C. and stirred for 3 hours until a large amount of white solid precipitated. The heating was stopped, and the temperature was lowered to room temperature. The filter cake was washed with a small amount of ethanol and dried at normal pressure at 50° C. for 12 hours to obtain three. Phenyl candesartan (white crystalline powder, 14.5 kg). Calculated according to the following formula, the yield of this step is 94.0percent.
90% With triethylamine In acetone at 55 - 60℃; for 4 - 8 h; Examples-l; Preparation of tritylated Candesartan acid (acetone) A mixture of Candesartan acid, triethylamine and acetone was heated to reflux temperature at 55-600C. To this trityl chloride solution in acetone was added and refluxed it for 4-8 hours. The reaction mixture was cooled at ambient temperature followed by addition of D. M. water and stirred for one hour. The reaction mixture was filtered and washed with mixture of acetone and D. M. water. To the solid, D. M water was added and stirred for 30 minutes at ambient temperature. The mixture was filtered and washed with D. M. water. The solid was dried to obtain tritylated Candesartan acid. Yield: 90 percent Purity: 99percent
90% With triethylamine In acetone at 55 - 60℃; A mixture of Candesartan acid, triethylamine and acetone was heated to reflux temperature at 55-60° C. To this trityl chloride solution in acetone was added and refluxed it for 4-8 hours. The reaction mixture was cooled at ambient temperature followed by addition of D. M. water and stirred for one hour. The reaction mixture was filtered and washed with mixture of acetone and D. M. water. To the solid, D. M water was added and stirred for 30 minutes at ambient temperature. The mixture was filtered and washed with D. M. water. The solid was dried to obtain tritylated Candesartan acid.Yield: 90percentPurity: 99percent
89% With triethylamine In methyl iso-butyl ketone (MIBK) at 55 - 60℃; for 4 - 8 h; ExampIes-2; Preparation of tritylated Candesartan acid (MIBK)A mixture of Candesartan acid, triethylamine and methyl isobutyl ketone (MIBK) was heated to reflux temperature at 55-600C. To this trityl chloride solution in MIBK was added and refluxed it for 4-8 hours. The reaction mixture was cooled at ambient temperature followed by addition of D. M. water and stirred for one hour. The reaction mixture was filtered and washed with mixture of acetone and D. M. water. To the solid, D. M water was added and stirred for 30 minutes at ambient temperature. The mixture was filtered and washed with D. M. water. The solid was dried to obtain tritylated Candesartan acid. Yield: 89 percent Purity: 98.5percent
88% With triethylamine In butanone at 55 - 60℃; for 4 - 8 h; Examples-3; Preparation of tritylated Candesartan acid (MEK) A mixture of Candesartan acid, triethylamine and methyl ethyl ketone (MEK) was heated to reflux temperature at 55-600C. To this trityl chloride solution in MEK was added and refluxed it for 4-8 hours. The reaction mixture was cooled at ambient temperature followed by addition of D. M. water and stirred for one hour. The reaction mixture was filtered and washed with mixture of acetone and D. M. water. To the solid, D. M water was added and stirred for 30 minutes at ambient temperature. The mixture was filtered and washed with D. M. water. The solid was dried to obtain tritylated Candesartan acid. Yield: 88 percent .bul. Purity: 98percent
83.8% With triethylamine In dichloromethane at 25 - 30℃; for 2 h; Heating / reflux Example-1: Preparation of Candesartan cilexetil (with isolation of cilexetil trityl candesartan); Step-I: Preparation of Trityl candesartanTo solution of Candesartan (10Og in 350 ml MDC) and triethyl amine (34.3 g) Trityl chloride (76.8g in 150 ml MDC) is added slowly at temperature of 25 - 3O0C. Temperature of the reaction mass is raised and maintained at reflux temperature for 2 hrs. Reaction mass is cooled to temperature of 30 - 350C, water (100 ml) is added, stirred for about 15 min, allowed to settle and separated the layers. Aqueous layer is extracted with MDC (2x 100 ml), combined organic layer is washed with water and MDC is removed below 5O0C from organic layer. Ethyl acetate (600 ml) is added, raised and maintained the temperature of the reaction mass at reflux temperature for 2hrs. The temperature of the mass is cooled, maintained for 1 hr at 25 - 3O0C and isolated the product by filtration. Wet cake is washed with ethyl acetate (100 ml) and dried at temperature of 45 - 5O0C to constant weight. <n="7"/>The weight of trityl candesartan is 130 g (Yield 83.8percent)
53% With triethylamine In dichloromethane at 20℃; for 2.5 h; To a solution of 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-benzimidazole-7-carboxylic acid (78 mg) in methylene chloride (1ml) were added trityl chloride (63 mg) and triethylamine (0.03ml). The mixture was stirred at room temperature for two hours thirty minutes. The reaction mixture was washed with water, dried and concentrated to dryness. The residue was purified by column chromatography on silica (eluant: cyclohexane /ethyl acetate: from to 90/10 to 0/100) to give 2-ethoxy-1-[{2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]-1,1'-biphenyl-4-yl}methyl]-benzimidazole-7-carboxylic acid (60mg, 53percent yield) as a white solid. 1H-NMR (400MHz, CDCl3) δ 1.40 (t, J=7Hz, 3H), 4.62 (q, J=7Hz, 2H), 5.59 (s, 2H), 6.76 (d, J=8Hz, 2H), 6.92-6.96 (m, 8H), 7.14 (t, J=8Hz, 1 H), 7.19-7.30 (m, 10H), 7.38 (m, 2H), 7.64 (d, J=8Hz, 1 H), 7.76-7.83 (m, 2H) ppm.
125.5 g With triethylamine In dichloromethane at 25 - 35℃; for 20 h; 250 g of tributyl tin azide was added into 600 ml of xylene. 100 g of candesartan cyclic compound (in formula II, R is ethyl) was added, heated to 140-150° C., and refluxed to react for 20 h. After the end of the reaction, the reaction mixture was cooled to 40-50° C. 600 ml of sodium hydroxide solution (48 g of sodium hydroxide dissolved in 600 ml of water) was added, and stirred under 20-35° C. (0032) The organic layer was removed. (0033) The alkaline aqueous layer was heated to 70-80° C. to completely hydrolyze candesartan ethyl ester. The temperature of the mixture was controlled at 25-35° C. 400 ml of dichloromethane was added. Glacial acetic acid was added dropwise to adjust pH of the mixture to 5-6 to precipitate candesartan. (0034) Triethylamine was added dropwise into the mixture until the candesartan solid was dissolved completely. The dichloromethane layer was separated. The aqueous layer was extracted by adding 200 ml of dichloromethane once again. The organic layers were combined. 68 g of triphenyl chloromethane was added into the organic layer. The temperature of the mixture was controlled at 25-35° C. to react until the content of candesartan was reduced to less than 1.0percent monitored by HPLC. After the end of the reaction, 100 ml of water was added for washing. The aqueous layer was removed. The organic layer was dried under reduced pressure. 600 ml of anhydrous ethanol was added to crystallize. The resulting crystals were collected by filtration, and dried to provide 125.5 g of trityl candesartan, yield 78.2percent, purity 97

Reference: [1] Patent: CN105153124, 2018, B, . Location in patent: Paragraph 0005; 0054; 0055; 0076; 0090
[2] Patent: WO2009/7986, 2009, A1, . Location in patent: Page/Page column 13
[3] Patent: US2010/210852, 2010, A1, . Location in patent: Page/Page column 5
[4] Patent: WO2009/7986, 2009, A1, . Location in patent: Page/Page column 14
[5] Patent: WO2009/7986, 2009, A1, . Location in patent: Page/Page column 14
[6] Patent: WO2007/94015, 2007, A1, . Location in patent: Page/Page column 5-6
[7] Patent: EP1833801, 2008, B1, . Location in patent: Page/Page column 18
[8] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 23, p. 7971 - 7977
[9] Patent: WO2006/50922, 2006, A1, . Location in patent: Page/Page column 12
[10] Patent: WO2009/157001, 2009, A2, . Location in patent: Page/Page column 4
[11] Patent: WO2011/92666, 2011, A1, . Location in patent: Page/Page column 12
[12] Patent: WO2011/145100, 2011, A1, . Location in patent: Page/Page column 7-8
[13] Patent: US2018/155326, 2018, A1, . Location in patent: Paragraph 0031-0034
  • 58
  • [ 76-83-5 ]
  • [ 139481-59-7 ]
  • [ 139481-72-4 ]
YieldReaction ConditionsOperation in experiment
66% With triethylamine In dichloromethane WORKING EXAMPLE 6
2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid
To a solution of 2-ethoxy-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid (2.07 g) in methylene chloride (10 ml) were added trityl chloride (1.59 g) and triethylamine (0.8 ml).
The mixture was stirred at room temperature for one hour.
The reaction mixture was washed with water, dried and concentrated to dryness.
The residue was purified by column chromatography on silica gel to give crystals.
Recrystallization of crude crystals thus obtained from ethyl acetate-benzene gave colorless crystals (2.12 g, 66percent), m.p. 168°-170° C.
1 H-NMR(200 MHz, CDCl3) δ: 1.40(3H,t), 4.61(2H,q), 5.58(2H,s), 6.76(2H,d), 6.91-6.96(8H,m), 7.12(1H,t), 7.17-7.41(12H,m), 7.60(1H,dd), 7.73-7.82(2H,m)
Reference: [1] Patent: US5196444, 1993, A,
  • 59
  • [ 821-25-0 ]
  • [ 76-83-5 ]
  • [ 139481-59-7 ]
  • [ 139481-72-4 ]
Reference: [1] Patent: US6177587, 2001, B1,
  • 60
  • [ 76-83-5 ]
  • [ 5401-94-5 ]
  • [ 942189-39-1 ]
YieldReaction ConditionsOperation in experiment
10%
Stage #1: With bromine In methanol
Stage #2: With sodium hydride In N,N-dimethyl-formamide
(S)-N-(3-(6-isopropoxypyridin-3-yl)- 1H-indazol-5-yl)- 1 -(2-(4-(4-(1 -methyl-1H- 1 ,2,4-triazol-3 -yl)phenyl)-3 , 6-dihydropyridin- 1 (2H)-yl)-2-oxoethyl)-3 -(methylthio)pyrrolidine3-carboxamide free base synthesis is a 19 step process. Compound preparation is divided into three intermediate preparations A, B and C followed by coupling of the intermediates. Allintermediates start with commercially available compounds. Compound 5 is prepared by reaction of the commercially available bromo-4-cyanobenzene with methyl hydrazine under acidic conditions to form the hydrazinoimidate 2 in modest yield. After reaction with formic acid in two steps the bromophenyl-N-methyl triazole intermediate 3 is obtained. The tetrahydropyridine ring is introduced by a Suzuki reaction of the commercially available Bocprotected tetrahydropyridine-boronate to obtain the tricyclic ring system 4. Chloroacetamide 5 is obtained in excellent yield by reaction of the deprotected 4 with chloroacetylchloride. The pyrrolidine core lOa is obtained in good yield in 5 steps starting from commercially available 6. Reaction with thionylchloride gave the thiomethyl olefin 7. Cycloaddition (2+3) gives 8 followed by removal of the benzyl protection group to give 9. L-Tartaric acid resolution of thepyrrolidine core gives the pure (5) enantiomer 9 after filtration from methanol. After protection as the Boc derivative and hydrolysis of the methyl ester, 10 is obtained in overall 50percent yield. Compound 17 is obtained from commercially available indazole 11. Bromination at the 3- position of indazole 11 proceeds in excellent yield without chromatography to obtain 12. Suzuki reaction of the bromo compound 12 with 14 gives the nitro indazole 16 after chromatography.Reduction of 16 gives aniline 17 as an oil in quantitative yield without chromatography. The final coupling of the intermediates proceeded by coupling 17 with lOa to obtain 18 in good yield. After deprotection of the Boc and Trityl groups the final coupling with 5 gave (S)-N-(3-(6- isopropoxypyridin-3-yl)- 1H-indazol-5-yl)-1 -(2-(4-(4-(1 -methyl-1H- 1 ,2,4-triazol-3-yl)phenyl)- 3 ,6-dihydropyridin- 1 (2H)-yl)-2-oxoethyl)-3 -(methylthio)pyrrolidine-3 -carboxamide afterchromatography. Final purification is carried out by crystallization from methanol/diethylether.This synthetic route has been conducted on a scale that delivered (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)- 1 -(2-(4-(4-(1 -methyl-1H- 1 ,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1 (2H)-yl)-2-oxoethyl)-3 -(methylthio)pyrroli dine-3 -carboxamide free base (Compound I).
Reference: [1] Patent: WO2016/100152, 2016, A1, . Location in patent: Page/Page column 8; 10
[2] Patent: WO2016/100147, 2016, A1, . Location in patent: Page/Page column 5; 8
[3] Patent: WO2017/40362, 2017, A1, . Location in patent: Page/Page column 4; 6
  • 61
  • [ 76-83-5 ]
  • [ 144689-23-6 ]
  • [ 144690-33-5 ]
YieldReaction ConditionsOperation in experiment
89% With triethylamine In dichloromethane at 0 - 30℃; for 15.5 h; To BIH (100 g, 1 eq) was added methylene chloride (500 mL, 5 vol), and the mixture was dissolved. Triethylamine (32.3 mL, 1.1 eq) was added thereto, and the reaction mixture was cooled to 0°C - 5°C. A solution of trityl chloride (63.22 g, 1.08 eq) in methylene chloride (300 mL, 3 vol) was slowly added thereto at 0°C - 5°C over 30 min, and the reaction mixture was stirred at 25°C - 30°C for 12 hr. Trityl chloride (2.92 g, 0.05 eq) was added, and the reaction mixture was further stirred for 3 hr. Using TLC (thin layer chromatography) (TLC eluent: 10percent methanol/methylene chloride, detection method: UV), complete disappearance of BIH was confirmed. [0300] The reaction mixture was cooled to 0°C - 5°C, desalting water (270 mL, 2.7 vol) was added, and the mixture was stirred at 25°C - 30°C for 15 min. The mixture was left standing and partitioned. The aqueous layer was extracted with methylene chloride (200 mL, 2 vol), the extracts were combined with the organic layer, and the mixture was washed with deionized water (500 mL, 5vol). The organic layer was dried over sodium sulfate and filtered, and the filtrate was concentrated under reduced pressure at 40°C - 45°C to give BIT (135 g, 89percent).
75.4% With triethylamine In dichloromethane at 0 - 25℃; for 4.5 h; Example 1-3 (0323) (0324) To a mixture of BIH (0.656 g, 1.38 mmol), triethylamine (0.22 mL, 1.52 mmol) and methylene chloride (7.8 mL, 12 vol) was added a solution of trityl chloride (0.416 g, 1.49 mmol) in methylene chloride (1.5 mL) at 0-5° C., and the mixture was stirred at the same temperature for 1 hr and at 25° C. for 3.5 hr. The reaction mixture was concentrated under reduced pressure, and the concentrated residue was purified by silica gel column chromatography (17-18percent ethyl acetate/hexane) to give BIT (746 mg, yield 75.4percent). (0325) 1H NMR (CDCl3): δ=7.88 (d, J=1.6 Hz, 1H), 7.50-7.44 (m, 2H), 7.37-7.24 (m, 6H), 7.09 (d, J=8.4 Hz, 2H), 6.96-6.94 (m, 6H), 6.72 (d, J=8.4 Hz, 2H), 5.81 (s, 1H), 5.35 (s, 2H), 4.13 (q, J=7.2 Hz, 2H), 2.51 (t, J=7.6 Hz, 2H), 1.64 (s, 6H), 1.69-1.61 (m, 2H), 1.08 (t, J=7.2 Hz, 3H), 0.88 (t, J=7.2 Hz, 3H); (0326) Mass: 717.6 [M+H]+.
Reference: [1] Patent: EP2891650, 2015, A1, . Location in patent: Paragraph 0298-0300
[2] Patent: US2015/239854, 2015, A1, . Location in patent: Page/Page column 39
Same Skeleton Products
Historical Records